{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T20:47:41Z","timestamp":1780519661635,"version":"3.54.1"},"reference-count":11,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies suggest that intranasal vaccination can stimulate nonspecific immunity against agents not contained within the vaccine, but this effect is not reported for cats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>A modified live feline herpesvirus-1 (FHV-1) and feline calicivirus (FCV) intranasal vaccine will reduce clinical signs of disease caused by experimental infection with Bordetella bronchiseptica.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Twenty specific pathogen-free 12-week-old kittens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Experimental study. Cats were randomized into 2 groups of 10 cats each. The vaccinated group was administered a single intranasal dose of a commercially available vaccine containing modified live strains of FHV-1 and FCV, and the control group remained unvaccinated. All 20 cats were administered B. bronchiseptica by nasal inoculation 7\u00a0days later and were observed daily for clinical signs of illness for 20\u00a0days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the first 10\u00a0days after B. bronchiseptica challenge, vaccinated cats were less likely to be clinically ill than control cats with a median clinical score of 0\/180 (range 0\u20135) versus 2\/180 (range 0\u20138) (P\u00a0=\u00a0.01). Nine of 10 control cats and 2 of 10 vaccinated cats were recorded as sneezing during days 1\u201310 after challenge (P\u00a0=\u00a0.006).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Intranasal vaccination against FHV-1 and FCV decreased signs of illness due to an infectious agent not contained in the vaccine. This nonspecific immunity could be beneficial for protection against organisms for which vaccines are not available and as protection before development of vaccine-induced humoral immunity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1939-1676.2012.00982.x","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T14:52:44Z","timestamp":1344005564000},"page":"1121-1125","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy of Intranasal Administration of a Modified Live Feline Herpesvirus 1 and Feline Calicivirus Vaccine against Disease Caused by\n                    <i>Bordetella bronchiseptica<\/i>\n                    after Experimental Challenge"],"prefix":"10.1093","volume":"26","author":[{"given":"A.","family":"Bradley","sequence":"first","affiliation":[{"name":"of Clinical Sciences Department , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kinyon","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, Iowa State University , Ames, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frana","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, Iowa State University , Ames, IA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Bolte","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, Colorado State University , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Hyatt","sequence":"additional","affiliation":[{"name":"Veterinary Diagnostic Laboratory, Colorado State University , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"Lappin","sequence":"additional","affiliation":[{"name":"of Clinical Sciences Department , Fort Collins, CO"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,9,1]]},"reference":[{"key":"2026020304165565700_jvim982-bib-0001","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2460\/javma.2005.227.579","article-title":"Assessment of infectious organisms associated with chronic rhinosinusitis in cats","volume":"227","author":"Johnson","year":"2005","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304165565700_jvim982-bib-0002","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cvsm.2008.03.002","article-title":"Molecular virology of feline calicivirus","volume":"38","author":"Pesavento","year":"2008","journal-title":"Vet Clin Small Anim"},{"key":"2026020304165565700_jvim982-bib-0003","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2460\/ajvr.2005.66.1550","article-title":"Relative sensitivity of polymerase chain reaction assays used for detection of feline herpesvirus type 1 DNA in clinical samples and commercial vaccines","volume":"66","author":"Maggs","year":"2005","journal-title":"Am J Vet Res"},{"key":"2026020304165565700_jvim982-bib-0004","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jfms.2008.04.002","article-title":"Prevalence of selected infectious organisms and comparison of two anatomic sampling sites in shelter cats with upper respiratory tract disease","volume":"10","author":"Veir","year":"2008","journal-title":"J Feline Med Surg"},{"key":"2026020304165565700_jvim982-bib-0005","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.2460\/javma.229.9.1405","article-title":"The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report","volume":"229","author":"Richards","year":"2006","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304165565700_jvim982-bib-0006","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jfms.2008.05.004","article-title":"Feline panleukopenia virus, feline herpesvirus-1, and feline calicivirus antibody responses in seronegative specific pathogen-free cats after a single administration of two different modified live FVRCP vaccines","volume":"11","author":"Lappin","year":"2009","journal-title":"J Feline Med Surg"},{"key":"2026020304165565700_jvim982-bib-0007","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jfms.2005.12.001","article-title":"Effects of a single dose of an intranasal feline herpesvirus 1, calicivirus, and panleukopenia vaccine on clinical signs and virus shedding after challenge with virulent feline herpesvirus 1","volume":"8","author":"Lappin","year":"2006","journal-title":"J Feline Med Surg"},{"key":"2026020304165565700_jvim982-bib-0008","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/vr.150.14.439","article-title":"Studies of the efficacy of a novel intranasal vaccine against feline bordetellosis","volume":"150","author":"Williams","year":"2002","journal-title":"Vet Rec"},{"key":"2026020304165565700_jvim982-bib-0009","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1128\/JVI.02542-09","article-title":"Attenuated Bordetella pertussis protects against highly pathogenic influenza A viruses by dampening the cytokine storm","volume":"84","author":"Li","year":"2010","journal-title":"J Virol"},{"key":"2026020304165565700_jvim982-bib-0010","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4049\/jimmunol.171.3.1133","article-title":"Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice","volume":"171","author":"Abe","year":"2003","journal-title":"J Immunol"},{"key":"2026020304165565700_jvim982-bib-0011","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/jmv.20837","article-title":"Prophylactic effects of chitin microparticles on highly pathogenic H5N1 influenza virus","volume":"79","author":"Ichinohe","year":"2007","journal-title":"J Med Virol"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1939-1676.2012.00982.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/26\/5\/1121\/66683311\/jvim982.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/26\/5\/1121\/66683311\/jvim982.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:17:12Z","timestamp":1770110232000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/26\/5\/1121\/8451587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,1]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,9,1]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1939-1676.2012.00982.x","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2012,9]]},"published":{"date-parts":[[2012,9,1]]}}}